These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts. Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228 [TBL] [Abstract][Full Text] [Related]
26. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study]. Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F; Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482 [TBL] [Abstract][Full Text] [Related]
27. Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time? Argollo M; Gilardi D; Roda G; Fiorino G; Peyrin-Biroulet L; Danese S Curr Pharm Des; 2019; 25(1):47-56. PubMed ID: 30848192 [TBL] [Abstract][Full Text] [Related]
29. Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn's disease: preliminary experience. Kovanlikaya A; Beneck D; Rose M; Renjen P; Dunning A; Solomon A; Sockolow R; Brill PW Abdom Imaging; 2015 Jun; 40(5):1068-74. PubMed ID: 25248794 [TBL] [Abstract][Full Text] [Related]
30. Comparison of noncontrast MRI magnetization transfer and T2 -Weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn's disease animal model. Dillman JR; Swanson SD; Johnson LA; Moons DS; Adler J; Stidham RW; Higgins PD J Magn Reson Imaging; 2015 Sep; 42(3):801-10. PubMed ID: 25504823 [TBL] [Abstract][Full Text] [Related]
31. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Heliö T; Halme L; Lappalainen M; Fodstad H; Paavola-Sakki P; Turunen U; Färkkilä M; Krusius T; Kontula K Gut; 2003 Apr; 52(4):558-62. PubMed ID: 12631669 [TBL] [Abstract][Full Text] [Related]
32. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease. Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779 [TBL] [Abstract][Full Text] [Related]
33. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777 [TBL] [Abstract][Full Text] [Related]
34. Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis. Goffin L; Fagagnini S; Vicari A; Mamie C; Melhem H; Weder B; Lutz C; Lang S; Scharl M; Rogler G; Chvatchko Y; Hausmann M Inflamm Bowel Dis; 2016 Sep; 22(9):2041-57. PubMed ID: 27542125 [TBL] [Abstract][Full Text] [Related]
35. Mycobacteria in Crohn's disease: a persistent hypothesis. Behr MA; Schurr E Inflamm Bowel Dis; 2006 Oct; 12(10):1000-4. PubMed ID: 17012971 [TBL] [Abstract][Full Text] [Related]
36. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054 [TBL] [Abstract][Full Text] [Related]
37. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Abreu MT; Taylor KD; Lin YC; Hang T; Gaiennie J; Landers CJ; Vasiliauskas EA; Kam LY; Rojany M; Papadakis KA; Rotter JI; Targan SR; Yang H Gastroenterology; 2002 Sep; 123(3):679-88. PubMed ID: 12198692 [TBL] [Abstract][Full Text] [Related]
38. Alterations of the CARD15/NOD2 gene and the impact on management and treatment of Crohn's disease patients. Török HP; Glas J; Lohse P; Folwaczny C Dig Dis; 2003; 21(4):339-45. PubMed ID: 14752224 [TBL] [Abstract][Full Text] [Related]
39. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960 [TBL] [Abstract][Full Text] [Related]
40. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Büning C; Genschel J; Bühner S; Krüger S; Kling K; Dignass A; Baier P; Bochow B; Ockenga J; Schmidt HH; Lochs H Aliment Pharmacol Ther; 2004 May; 19(10):1073-8. PubMed ID: 15142196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]